Exploring Methylphenidate-Induced Intraocular Pressure: A Cautionary Tale in Pediatric ADHD Management
Selman Yıldırım1, Mahya Özel1, Murat Günay2
1Department of Child and Adolescent Psychiatry, Faculty of Medicine, Karadeniz Technical University, Trabzon, Türkiye.
Methylphenidate (MTX) can increase intraocular pressure (IOP) in children, especially those with pre-existing eye conditions. Careful monitoring and alternative treatments like atomoxetine are crucial for managing attention deficit hyperactivity disorder safely.
Area of Science:
- Ophthalmology
- Pediatrics
- Pharmacology
Background:
- Methylphenidate (MTX) is a central nervous system stimulant used for Attention Deficit Hyperactivity Disorder (ADHD).
- Existing literature suggests a potential link between MTX and elevated intraocular pressure (IOP).
- Nuanced risk factors for MTX-induced IOP elevation require further investigation.
Observation:
- A 6-year-old girl with ADHD and a family history of eye conditions developed increased IOP after 12 days of MTX treatment.
- The patient presented with high hyperopia, a potential contributing factor to IOP elevation.
- MTX was discontinued due to the observed increase in IOP.
Findings:
- The patient's IOP normalized after MTX discontinuation.
- Transitioning to atomoxetine resulted in normalized IOP and improved attention duration.
- High hyperopia may exacerbate the effect of MTX on IOP in susceptible pediatric patients.
Implications:
- This case highlights the importance of considering pre-existing eye conditions and family history when prescribing MTX in pediatric ADHD patients.
- Close monitoring of IOP is recommended for children on MTX, particularly those with risk factors like hyperopia.
- Individualized treatment strategies and careful patient selection are essential for safe and effective ADHD management.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
09:26A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
Published on: March 23, 2016
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Angle Closure Glaucoma: Treatment
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
